PURPOSE: The brain is a common site of metastasis for patients with high-risk melanoma. Although surgery or stereotactic radiosurgery are highly effective local treatments for a small number of metastases, there is a high risk of developing additional brain metastases. The role of adjuvant whole-brain radiotherapy (WBRT) in reducing new metastases is controversial, with a lack of high-level evidence specifically for melanoma. METHODS: In this randomized phase III trial, patients who had local treatment of one to three melanoma brain metastases were randomly assigned to WBRT or observation. The primary end point was distant intracranial failure within 12 months, and secondary end points included time to intracranial failure, survival, and ti...
Background: The clinical value of whole brain radiotherapy (WBRT) for brain metastases (BM) is a mat...
Background: The clinical value of whole brain radiotherapy (WBRT) for brain metastases (BM) is a mat...
Background: Maintenance of quality of life is the primary goal during treatment of brain metastases ...
Purpose The brain is a common site of metastasis for patients with high-risk melanoma. Although surg...
Purpose The brain is a common site of metastasis for patients with high-risk melanoma. Although surg...
Cerebral metastases are a common cause of death in patients with melanoma. Systemic drug treatment o...
BACKGROUND: The WBRTMel trial is a multinational, open-label, phase III randomised controlled trial ...
Full list of author information is available at the end of the articleBackground Brain metastases (B...
International audienceBackground: Melanoma brain metastases (MBMs) are historically associated with ...
International audienceBackground: Melanoma brain metastases (MBMs) are historically associated with ...
Purpose This European Organisation for Research and Treatment of Cancer phase III trial assesses whe...
Purpose This European Organisation for Research and Treatment of Cancer phase III trial assesses whe...
Purpose This European Organisation for Research and Treatment of Cancer phase III trial assesses whe...
Background: The clinical value of whole brain radiotherapy (WBRT) for brain metastases (BM) is a mat...
Background: The clinical value of whole brain radiotherapy (WBRT) for brain metastases (BM) is a mat...
Background: The clinical value of whole brain radiotherapy (WBRT) for brain metastases (BM) is a mat...
Background: The clinical value of whole brain radiotherapy (WBRT) for brain metastases (BM) is a mat...
Background: Maintenance of quality of life is the primary goal during treatment of brain metastases ...
Purpose The brain is a common site of metastasis for patients with high-risk melanoma. Although surg...
Purpose The brain is a common site of metastasis for patients with high-risk melanoma. Although surg...
Cerebral metastases are a common cause of death in patients with melanoma. Systemic drug treatment o...
BACKGROUND: The WBRTMel trial is a multinational, open-label, phase III randomised controlled trial ...
Full list of author information is available at the end of the articleBackground Brain metastases (B...
International audienceBackground: Melanoma brain metastases (MBMs) are historically associated with ...
International audienceBackground: Melanoma brain metastases (MBMs) are historically associated with ...
Purpose This European Organisation for Research and Treatment of Cancer phase III trial assesses whe...
Purpose This European Organisation for Research and Treatment of Cancer phase III trial assesses whe...
Purpose This European Organisation for Research and Treatment of Cancer phase III trial assesses whe...
Background: The clinical value of whole brain radiotherapy (WBRT) for brain metastases (BM) is a mat...
Background: The clinical value of whole brain radiotherapy (WBRT) for brain metastases (BM) is a mat...
Background: The clinical value of whole brain radiotherapy (WBRT) for brain metastases (BM) is a mat...
Background: The clinical value of whole brain radiotherapy (WBRT) for brain metastases (BM) is a mat...
Background: Maintenance of quality of life is the primary goal during treatment of brain metastases ...